NPI: 1659822633 · OCEANSIDE, CA 92056 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/14/2016
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 10/14/2016 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 6,056 | $609K |
| 2020 | 5,369 | $521K |
| 2021 | 7,352 | $478K |
| 2022 | 11,752 | $847K |
| 2023 | 10,011 | $906K |
| 2024 | 9,289 | $1.21M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 26,667 | 2,239 | $4.47M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,232 | 939 | $43K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,047 | 709 | $24K |
| J1756 | Injection, iron sucrose, 1 mg | 4,154 | 1,309 | $19K |
| A4657 | Syringe, with or without needle, each | 1,046 | 514 | $10K |
| 0250 | 3,678 | 250 | $6K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 1,816 | 182 | $1K |
| 90674 | 55 | 55 | $159.81 | |
| 83970 | 271 | 251 | $103.41 | |
| 83550 | 201 | 178 | $21.17 | |
| 90662 | 13 | 13 | $16.98 | |
| 83540 | 238 | 214 | $16.84 | |
| 82728 | 212 | 191 | $14.44 | |
| 85041 | 553 | 512 | $13.12 | |
| 85048 | 550 | 510 | $11.14 | |
| 82108 | 29 | 25 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 67 | 50 | $0.00 |